Molecular characteristics of pancreatic ductal adenocarcinoma
about
Is metastatic pancreatic cancer an untargetable malignancy?Epidermal growth factor receptor signaling pathway is frequently altered in ampullary carcinoma at protein and genetic levels.Low expression of the E3 ubiquitin ligase CBL confers chemoresistance in human pancreatic cancer and is targeted by epidermal growth factor receptor inhibition.Next generation sequencing improves the accuracy of KRAS mutation analysis in endoscopic ultrasound fine needle aspiration pancreatic lesions.Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinomaMolecular mechanisms involved in the synergistic interaction of the EZH2 inhibitor 3-deazaneplanocin A with gemcitabine in pancreatic cancer cells.Integrated stress response is critical for gemcitabine resistance in pancreatic ductal adenocarcinomaMicro-RNA-155 is induced by K-Ras oncogenic signal and promotes ROS stress in pancreatic cancer.Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancer.Genomic sequencing of key genes in mouse pancreatic cancer cells.Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation.Advances in membrane proteomics and cancer biomarker discovery: current status and future perspective.Notch signaling in pancreatic cancer: oncogene or tumor suppressor?The aberrant overexpression of vimentin is linked to a more aggressive status in tumours of the gastrointestinal tract.Human pancreatic cancer progression: an anarchy among CCN-siblings.Measurement of protein kinase B activity in single primary human pancreatic cancer cells.Targeting elongation factor-2 kinase (eEF-2K) induces apoptosis in human pancreatic cancer cells.Galeterone and its analogs inhibit Mnk-eIF4E axis, synergize with gemcitabine, impede pancreatic cancer cell migration, invasion and proliferation and inhibit tumor growth in miceEpicatechin-rich cocoa polyphenol inhibits Kras-activated pancreatic ductal carcinoma cell growth in vitro and in a mouse model.
P2860
Q26753849-525CE99D-5939-4D4B-B6FA-626AEB81F539Q33556032-7E43E4BC-82A6-4329-B369-FDE4FC5654CAQ34861855-98BCBC32-ED5F-47C0-9FBB-A3832B4F6236Q35087934-EEB20F3D-F827-4EE7-9C49-5E415AA7CD48Q35247604-893DF4C9-FD75-4484-B819-FA4DD2A145BEQ36157197-FF60222B-6E62-4041-B37C-51B6424701F7Q36246425-E1712C06-DB00-4841-8560-FD2F98FFB926Q36356269-9EB97617-5D4F-442B-AB73-C611E9E91420Q37030911-8D69AA7B-5087-4DE8-BEF0-17FCAB8E96F0Q37237804-42C1D734-3704-4AA3-B6BE-CB4125CE84A3Q37410628-B3C1C1F7-71F7-47D8-9198-D786CF80C9CAQ38034447-7FAF91BF-9ABC-4A4C-86D0-50EE9C086225Q38094850-AAA7EE7E-380D-40A8-8F04-9A51A64166DBQ38471210-2469295B-FA31-4C38-9514-0894E78E99D8Q38931858-5683DBE3-C8DB-4517-A37C-E19F0215B01CQ39005983-FC661F6D-D191-4BCD-AD5D-5DA0076CFC93Q39066768-CBC1D0D2-3F3E-42DD-BEE5-902F48C1B934Q41592725-D7F11936-1FE8-4D42-936D-8BAA7BB34D04Q53197134-201B34EF-CE03-4D8D-B971-15DBA6B4C253
P2860
Molecular characteristics of pancreatic ductal adenocarcinoma
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Molecular characteristics of pancreatic ductal adenocarcinoma
@ast
Molecular characteristics of pancreatic ductal adenocarcinoma
@en
Molecular characteristics of pancreatic ductal adenocarcinoma
@nl
type
label
Molecular characteristics of pancreatic ductal adenocarcinoma
@ast
Molecular characteristics of pancreatic ductal adenocarcinoma
@en
Molecular characteristics of pancreatic ductal adenocarcinoma
@nl
prefLabel
Molecular characteristics of pancreatic ductal adenocarcinoma
@ast
Molecular characteristics of pancreatic ductal adenocarcinoma
@en
Molecular characteristics of pancreatic ductal adenocarcinoma
@nl
P2093
P2860
P356
P1476
Molecular characteristics of pancreatic ductal adenocarcinoma
@en
P2093
Anirban Maitra
G Johan A Offerhaus
Niki A Ottenhof
Roeland F de Wilde
P2860
P304
P356
10.4061/2011/620601
P577
2011-03-27T00:00:00Z